SXC2023
SXC2023 is an inhibitor for solute carrier family 7 member 11 (SLC7A11) . SXC2023 exhibits antitumor efficacy, and ameliorates central nervous system disorder through downregulation of glutamate export[1].
Product Specifications
CAS Number
[1695562-36-7]
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Amino acid Transporter
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Cancer-programmed cell death
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/sxc2023.html
Purity
99.83
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
CC(N[C@H](C(O)=O)CSC(C1=CC=C(C=C1)C)=O)=O
Molecular Formula
C13H15NO4S
Molecular Weight
281.33
Precautions
H315, H319
References & Citations
[1]PENDERGAST AM, et al., Compositions and methods for the treatment cancer and cns disorders. WO2021030783 A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ID3 (1R21, BHLHB25, HEIR1, DNA-binding Protein Inhibitor ID-3, Class B Basic Helix-loop-helix Protein 25, Helix-loop-helix Protein HEIR-1, ID-like Protein Inhibitor HLH 1R21, Inhibitor of DNA Binding 3) (MaxLight 490)